Inspire Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of prescription products in disease areas with significant commercial markets and unmet medical needs. The Company's primary focus is in the ophthalmic and respiratory therapeutic areas where it has significant expertise. Its ophthalmic products and product candidates are concentrated in the allergic conjunctivitis, dry eye disease and retinal disease indications. Inspire is working on respiratory product candidates for the treatment of cystic fibrosis and upper respiratory disorders. Inspire has acquired the rights to market Elestat and Restasis in the United States under co-promotion agreements with Allergan.